In Conversation

"The BgMVO is actually the second organization of this kind to be legally established in Europe and we are aiming to be in the first five…

"Parallel exports are a completely legal and regulated business within the EU but it is clear that this is creating pressure due to the product deficit…

"Concerning the sanitary aspect, the CNSS manages six policlinics in the country as well as an orthopedic equipment center."

"Around 60 percent of Adwya’s turnover comes from licensing agreements the remaining 40 percent stem from generics."

"We have a team of more than 250 professionals that ensure the success of Novartis in Bulgaria and a total turnover of around EUR 90 million."

"In Bulgaria, we are present in both pharmaceuticals and diagnostics; the latter being way smaller in terms of revenues and size."

"SAIPH is a company spread over three regions whose objective was to become a multinational company with an international culture."

"In 2020, the BiotechPole will have successfully opened its Technology Research Center (CRT) that will encompass an operational production line and employees that are perfectly able…

"Fortunately, approximately half of the Canadian population is able to access drugs through private insurance, which allows for speedy coverage for most drugs used to treat…

"All innovation needs to be supported with medical education and Amgen globally has been really active in this regard targeting those therapeutic areas in which it…

"Today, government bureaucracy has become too involved in trying to manage the system from Québec City."

"As a company, we have been focusing only on birth, maternity and toddler skincare for the past 60 years, so this is indisputably our specialty areas."

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here